{"organizations": [], "uuid": "67d677faca0d83ffcad339ac5781a6bd7989f07a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180116.html", "section_title": "Archive News &amp; Video for Tuesday, 16 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/merck-co-study/mercks-keytruda-succeeds-in-key-lung-cancer-trial-idUSL3N1PB3WZ", "country": "US", "domain_rank": 408, "title": "Merck's Keytruda succeeds in key lung cancer trial", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.993, "site_type": "news", "published": "2018-01-16T20:00:00.000+02:00", "replies_count": 0, "uuid": "67d677faca0d83ffcad339ac5781a6bd7989f07a"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/merck-co-study/mercks-keytruda-succeeds-in-key-lung-cancer-trial-idUSL3N1PB3WZ", "ord_in_thread": 0, "title": "Merck's Keytruda succeeds in key lung cancer trial", "locations": [], "entities": {"persons": [{"name": "keytruda", "sentiment": "negative"}, {"name": "tamara mathias", "sentiment": "none"}], "locations": [{"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "merck", "sentiment": "negative"}, {"name": "reuters) - merck & co inc", "sentiment": "neutral"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 16 (Reuters) - Merck & Co Inc said on Tuesday that a key late-stage study testing its blockbuster drug Keytruda as a treatment for a type of lung cancer was successful.\nThe trial, which tested Keytruda as a first line treatment, met its main goals of preventing cancer from worsening and extending the overall survival of patients with metastatic non-squamous non-small-cell lung cancer.\nKeytruda has previously been approved to treat several forms of cancer including stomach cancer and skin cancer. (Reporting by Tamara Mathias in Bengaluru)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-16T20:00:00.000+02:00", "crawled": "2018-01-17T19:44:48.015+02:00", "highlightTitle": ""}